Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 20:2022:5249922.
doi: 10.1155/2022/5249922. eCollection 2022.

A Randomized, Double-Masked, Active-Controlled, Crossover Phase III Equivalence Study of Generic Dorzolamide 2% versus Innovator Trusopt® Eye Drop Solution in Subjects with Open-Angle Glaucoma or Ocular Hypertension

Katharina Bell  1 , Christina Korb  1 , Christina Butsch  1 , Bert Constantin Giers  1 , Anna Beck  1 , Alicja Strzalkowska  1 , Christian Ruckes  2 , Ulrike Klingberg  3 , Norbert Pfeiffer  1 , Katrin Lorenz  1
Affiliations

A Randomized, Double-Masked, Active-Controlled, Crossover Phase III Equivalence Study of Generic Dorzolamide 2% versus Innovator Trusopt® Eye Drop Solution in Subjects with Open-Angle Glaucoma or Ocular Hypertension

Katharina Bell et al. J Ophthalmol. .

Abstract

Background: The aim of this study was to demonstrate the equivalence of generic dorzolamide 2% eye drops solution versus the innovator formulation (Trusopt® eye drops solution) in patients with open-angle glaucoma or ocular hypertension.

Methods: This prospective, monocentric, double-masked, active-controlled crossover phase III study included 32 patients. After washout, patients were randomized to reference product (Trusopt®) or test product (dorzolamide 2% eye drops, Rompharm Company SRL) for a 4-week period. Subsequent washout and crossover were performed. Drops were applied t.i.d. The primary efficacy endpoint was the difference in mean diurnal IOP. Goldmann applanation tonometry was performed at 8 am, 12 pm, and 4 pm at each visit, and safety was assessed by documentation of adverse events (AEs). Therapy adherence was documented by self-reporting and eye drop bottle weighing. An ANOVA with treatment, sequence, study period, and patient within the sequence as effects was performed and an additional post hoc ANCOVA including the baseline IOP was also performed.

Results: 34 patients were randomized and analyzed in the safety population. The per-protocol population included 32 patients. According to the self-report, all patients were >80% compliant. Under the ANCOVA model, the 90% confidence interval for the average change of the IOP -0.27 mmHg (-1.17 mmHg-0.64 mmHg) is included by the acceptance range -1.5 mmHg to +1.5 mmHg after excluding 2 patients, which had falsely reported high therapy adherence. No clinically relevant difference was observed in frequency or severity of the AEs between both treatments.

Conclusions: This study showed the equivalence of the tested generic dorzolamide 2% eye drops solution to the reference product Trusopt® eye drops solution. Trial Registration. This trial is registered with (ClinicalTrials.gov (identifier: NCT00878917) on April 9, 2009).

PubMed Disclaimer

Conflict of interest statement

Ulrike Klingberg is an employee of the sponsor of the study. The other authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Study overview.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Quigley H. A. Open-angle glaucoma. New England Journal of Medicine . 1993;328(15):1097–1106. doi: 10.1056/nejm199304153281507. - DOI - PubMed
    1. Quigley H. A. Number of people with glaucoma worldwide. British Journal of Ophthalmology . 1996;80(5):389–393. doi: 10.1136/bjo.80.5.389. - DOI - PMC - PubMed
    1. Cedrone C., Nucci C., Scuderi G., Ricci F., Cerulli A., Culasso F. Prevalence of blindness and low vision in an Italian population: a comparison with other European studies. Eye . 2006;20(6):661–667. doi: 10.1038/sj.eye.6701934. - DOI - PubMed
    1. The Advanced Glaucoma Intervention Study. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators. American Journal of Ophthalmology . 2000;130(4):429–440. - PubMed
    1. Mao L. K., Stewart W. C., Shields M. B. Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma. American Journal of Ophthalmology . 1991;111(1):51–55. doi: 10.1016/s0002-9394(14)76896-5. - DOI - PubMed

Associated data

LinkOut - more resources